Advancing COVID-19 Related Research in Law and Science

In this episode of Campus Beat we feature two conversations with Queen’s faculty researchers.

In the first segment, we chat with Dr. Samuel Dahan from the Faculty of Law and Director of the Conflict Analytics Lab about his lab’s new Vaccine Mediator – a new COVID-19 vaccine online dispute resolution tool – and its development and implementation conducted in collaboration with researchers at Oxford University, University College Dublin, and the British Institute of International and Comparative Law.

Vaccine Mediator is an innovative third-party system that enables individuals to register potential side-effects and receive fast and reliable information about available compensation options. Leveraging an AI-powered legal aid platform, it pre-assesses compensation eligibility, provides a customized report and an easy to understand guide to help individuals submit a pre-drafted claim to the relevant government agency.

In the next segment around the 14:24 mark, we are joined by Dr. Maha Othman from the Department of Biomedical and Molecular Science.  Dr. Othman’s groundbreaking 2007 research on blood clots and adenovirus has recently been cited in numerous scholarly articles on vaccine-induced immune thrombotic thrombocytopenia (VITT) is an extremely rare side effect that happens in a subset of the population following AstraZeneca and Johnson and Johnson COVID-19 vaccinations.  From Othman, we learn about the research, its current applications in theory and scientific practice.